Particularly, ACE2-S binding affinity and neutralization resistance are the two major outcome dimensions, indicating the infection efficiency and immune evasion capacity, respectively, for each emerging SARS-CoV-2 variant during evolution (Huo et al., 2023; Ma et al., 2023; Zhao et al., 2023). The gene discussed is ACE2; the disease is infection.